Wilmington, DE, United States of America

David J Carini

This inventor holds 19 USPTO granted patents, primarily in Angiotensin II Antagonists. Top assignees: E.i. Dupont De Nemours and Company, The Dupont Merck Pharmaceutical Company. Active years: 1986-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David J Carini. Retrieved from https://idiyas.com/inventor/david-j-carini

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 14

Forward Citations = 613(Granted Patents)


Company Filing History:


Years Active: 1986-1998

Loading Chart...
Areas of Expertise:
Aminobornic Acids
Angiotensin II
Imidazoles
Antihypertensive
Benzimidazoles
Triazole
Chronic Renal Failure
Hypertension
Fused Aryl
Radioiodinated
Guanidino
Pyrazole
19 patents (USPTO):Explore Patents

Title: Innovator Spotlight: David J. Carini

Introduction

David J. Carini is a prominent inventor based in Wilmington, Delaware, recognized for his contributions to the field of medicinal chemistry. With a remarkable portfolio of 19 patents, Carini has established himself as a key player in the development of innovative compounds that impact drug discovery and design.

Latest Patents

Among his latest inventions, Carini has developed several notable patents that focus on the design of boronic acids and peptide analogs. One of his key patents, "Piperidine containing aminoboron acids," explores α-aminoboronic acids and their peptide analogs. These compounds feature an α-carbon that is substituted with a piperidine-containing alkyl group and have been identified as significant inhibitors of trypsin-like serine protease enzymes. Another notable patent is "Amidino and guanidino substituted boronic acid inhibitors," which presents novel α-amino acids and α-aminoboronic acid structures, showcasing Carini’s innovative approach to enhancing medicinal properties.

Career Highlights

David Carini has been affiliated with notable companies, including E.I. DuPont De Nemours and Company and The DuPont Merck Pharmaceutical Company. His work in these organizations has contributed significantly to the field of pharmaceutical science, particularly in the development of inhibitors that have potential therapeutic applications.

Collaborations

Throughout his career, Carini has collaborated with several distinguished professionals in the industry, including John J. Duncia and Pancras C. Wong. These collaborations have led to significant advancements in their respective research projects and have reinforced the importance of teamwork in the innovation process.

Conclusion

David J. Carini stands as a testament to the impactful contributions that inventors can make in science and technology. His work continues to inspire and enable advancements in medicinal chemistry, paving the way for new therapeutic options in the future. Carini's dedication and innovative spirit exemplify the essence of invention in the modern era.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…